Clinical Trial Update: Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating rapamycin for Alzheimer's disease using PET imaging has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Karolinska Institutet | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED